Pravafen 40 / 160 40 mg / 160 mg Hard capsules.
PDF Leaflet Revision Date: 15 August 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunct treatment for mixed hyperlipidaemia in high cardiovascular risk adults.
Dosage (summary)
One capsule daily with evening meal.
Special Populations
- Elderly patients
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Fusidic acid
- Ciclosporin
- Oral anticoagulants
Contraindications
- Severe hepatic impairment
- Moderate to severe renal impairment
- Hypersensitivity to components
- Children under 18
Common side effects
- Increased transaminases
- Gastrointestinal disorders
- Myalgia
Counselling Points
- Take with food to enhance absorption.
- Report unexplained muscle pain or weakness.
- Use effective contraception during treatment.
Serious warnings
- Risk of myopathy and rhabdomyolysis
- Monitor CK levels
- Increased risk of pancreatitis
Important Disclaimer
The Pravafen 40 / 160 40 mg / 160 mg Hard capsules. professional information leaflet below is the property of Austell Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
